Citation Tools

Download PDFPDF

278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer

Download to a citation manager

Cite this article as:
Blumenschein G, Devarakonda S, Johnson M, et al
278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer